BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 12101712)

  • 1. [Concurrent induction chemo-radiotherapy followed by surgery in lung cancer].
    Katakami N
    Nihon Rinsho; 2002 May; 60 Suppl 5():450-4. PubMed ID: 12101712
    [No Abstract]   [Full Text] [Related]  

  • 2. Mortality associated with pneumonectomy after induction chemoradiation versus chemotherapy alone in stage IIIA-N2 non-small cell lung cancer.
    Van Schil PE
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):718; author reply 718-9. PubMed ID: 18329516
    [No Abstract]   [Full Text] [Related]  

  • 3. Scalpels, beams, drugs, and dreams: challenges of stage IIIA-N2 non-small-cell lung cancer.
    Johnson DH; Rusch VW; Turrisi AT
    J Natl Cancer Inst; 2007 Mar; 99(6):415-8. PubMed ID: 17374824
    [No Abstract]   [Full Text] [Related]  

  • 4. A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209).
    Nagai K; Tsuchiya R; Mori T; Tada H; Ichinose Y; Koike T; Kato H;
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):254-60. PubMed ID: 12579093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chemotherapy for lung cancer].
    Kurata T; Fukuoka M
    Nihon Rinsho; 2002 May; 60 Suppl 5():309-16. PubMed ID: 12101679
    [No Abstract]   [Full Text] [Related]  

  • 6. [Advances in the diagnosis and treatment of lung cancer. I. Management of non-small cell carcinoma].
    Spiro SG
    Pneumonol Pol; 1990; 58(4-5):239-43. PubMed ID: 2168045
    [No Abstract]   [Full Text] [Related]  

  • 7. [Combined-modality therapy for lung cancer].
    Miura S; Yamamoto N
    Nihon Rinsho; 2010 Jun; 68(6):1121-8. PubMed ID: 20535966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic management of non-small-cell lung carcinoma (NSCLC) of stage III A].
    Mornex F
    Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S29-32. PubMed ID: 11924239
    [No Abstract]   [Full Text] [Related]  

  • 9. NCCN: Small cell lung cancer.
    Johnson BE;
    Cancer Control; 2001; 8(6 Suppl 2):32-43. PubMed ID: 11760556
    [No Abstract]   [Full Text] [Related]  

  • 10. Systemic treatment of non-small-cell lung cancer.
    Lal R; Enting D; Kristeleit H
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S375-7. PubMed ID: 21944021
    [No Abstract]   [Full Text] [Related]  

  • 11. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
    Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of localised forms of non small cell bronchial cancers: perspectives in 20003].
    Depierre A; Quoix E; Milleron B
    Rev Mal Respir; 2003 Apr; 20(2 Pt 1):173-6. PubMed ID: 12844012
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effect of chemo-radiotherapy on the remission and survival in patients with limited stage small cell lung cancer].
    Bozóky G; Ruby E; Góhér I; Gábor G; Mohos A; Lengyel M
    Orv Hetil; 2005 Jul; 146(27):1433-8. PubMed ID: 16089103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined modality treatment of lung cancer (NSCLC and SCLC).
    Delbaldo C; Le Péchoux C; Le Chevalier T
    Cancer Chemother Biol Response Modif; 2002; 20():677-95. PubMed ID: 12703230
    [No Abstract]   [Full Text] [Related]  

  • 15. [Impact of TNM staging and treatment mode on the prognosis of non-small cell lung cancer].
    Yu DP; Bai LQ; Xu SF; Han M; Wang ZT
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):465-8. PubMed ID: 19950561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Paclitaxel].
    Hino M; Kudo S
    Nihon Rinsho; 2002 May; 60 Suppl 5():343-8. PubMed ID: 12101685
    [No Abstract]   [Full Text] [Related]  

  • 17. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.
    van Meerbeeck JP; Kramer GW; Van Schil PE; Legrand C; Smit EF; Schramel F; Tjan-Heijnen VC; Biesma B; Debruyne C; van Zandwijk N; Splinter TA; Giaccone G;
    J Natl Cancer Inst; 2007 Mar; 99(6):442-50. PubMed ID: 17374834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined modality therapy for stage III non-small-cell lung cancer.
    Anderson CS; Curran WJ
    Semin Radiat Oncol; 2010 Jul; 20(3):186-91. PubMed ID: 20685581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of non-small-cell lung cancer.
    Hadeed VA; Jett JR
    Compr Ther; 1996 Oct; 22(10):641-8. PubMed ID: 8950080
    [No Abstract]   [Full Text] [Related]  

  • 20. [Our experience with patients operated after neoadjuvant therapy].
    Juhász M; Egri G; Váradi C; Mészáros Z; Keszler P
    Magy Seb; 2004 Dec; 57(6):332-5. PubMed ID: 15803876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.